MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer

Autocrine STAT3 activation in HPV positive cervical cancer through a virus-driven Rac1—NFκB—IL-6 signalling axis

(2019) Ethan L. Morgan et al.   PLoS Pathogens

JAK2 Inhibition Impairs Proliferation and Sensitises Cervical Cancer Cells to Cisplatin-Induced Cell Death

(2019) Ethan L. Morgan et al.   Cancers

Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer

(2018) Peixin Dong et al.   ONCOGENE

DNA damage response induced by Etoposide promotes steroidogenesis via GADD45A in cultured adrenal cells

(2018) Mimi Tamamori-Adachi et al.   Scientific Reports

STAT3 activation by E6 is essential for the differentiation-dependent HPV18 life cycle

(2018) Ethan L. Morgan et al.   PLoS Pathogens

The Role of MicroRNAs in the Metastatic Process of High-Risk HPV-Induced Cancers

(2018) Joana Santos et al.   Cancers

MicroRNAs in HPV associated cancers: small players with big consequences

(2017) Sandeep Satapathy et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma

(2017) Wantae Kim et al.   GUT

Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects

(2017) Elena Bekerman et al.   JOURNAL OF CLINICAL INVESTIGATION

MiR-590-3p promotes proliferation and metastasis of colorectal cancer via Hippo pathway

(2017) Zhen-Qiang Sun et al.   Oncotarget

Human papillomavirus type 18 E5 oncogene supports cell cycle progression and impairs epithelial differentiation by modulating growth factor receptor signalling during the virus life cycle

(2017) Christopher W. Wasson et al.   Oncotarget

Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach

(2017) Jiekai Yu et al.   Scientific Reports

MST1/MST2 Protein Kinases: Regulation and Physiologic Roles

(2016) Jacob A. Galan et al.   BIOCHEMISTRY

Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration

(2016) Fuqin Fan et al.   Science Translational Medicine

Analysis of Multiple HPV E6 PDZ Interactions Defines Type-Specific PDZ Fingerprints That Predict Oncogenic Potential

(2016) Miranda Thomas et al.   PLoS Pathogens

Targeting the ATP-dependent formation of herpesvirus ribonucleoprotein particle assembly as an antiviral approach

(2016) Sophie Schumann et al.   Nature Microbiology

The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression

(2015) Chunbo He et al.   EMBO Molecular Medicine

The Growing Epidemic of HPV-Positive Oropharyngeal Carcinoma: A Clinical Review for Primary Care Providers

(2015) K. A. Moore et al.   Journal of the American Board of Family Medicine

Deacetylation of tumor-suppressor MST1 in Hippo pathway induces its degradation through HBXIP-elevated HDAC6 in promotion of breast cancer growth

(2015) L Li et al.   ONCOGENE

MicroRNA-18a enhances the radiosensitivity of cervical cancer cells by promoting radiation-induced apoptosis

(2015) SHA LIU et al.   ONCOLOGY REPORTS

Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway

(2015) Meiyuan Chen et al.   Oncotarget

microRNAs are biomarkers of oncogenic human papillomavirus infections

(2014) X. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MicroRNA-18a is elevated in prostate cancer and promotes tumorigenesis through suppressing STK4 in vitro and in vivo

(2014) T-I Hsu et al.   Oncogenesis

The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment

(2013) Randy Johnson et al.   NATURE REVIEWS DRUG DISCOVERY

Inactivating All Three Rb Family Pocket Proteins Is Insufficient to Initiate Cervical Cancer

(2012) M.-K. Shin et al.   CANCER RESEARCH

Yes-Associated Protein 1 Is Activated and Functions as an Oncogene in Meningiomas

(2012) G. S. Baia et al.   MOLECULAR CANCER RESEARCH

Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis

(2012) S M Wilting et al.   ONCOGENE

Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancers

(2010) J T-C Chang et al.   CANCER GENE THERAPY

YAP is a candidate oncogene for esophageal squamous cell carcinoma

(2010) Tomoki Muramatsu et al.   CARCINOGENESIS

The Hippo Signaling Pathway in Development and Cancer

(2010) Duojia Pan   DEVELOPMENTAL CELL

A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF -TRCP

(2010) B. Zhao et al.   GENES & DEVELOPMENT

MST1 Promotes Apoptosis through Phosphorylation of Histone H2AX

(2010) Weihong Wen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene

(2009) Dawang Zhou et al.   CANCER CELL

Regulation of organ size: Insights from theDrosophilaHippo signaling pathway

(2009) Madhuri Kango-Singh et al.   DEVELOPMENTAL DYNAMICS

Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression

(2008) Luigi Scotto et al.   GENES CHROMOSOMES & CANCER